Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

26 results
Display

Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium

Park S, Yoon WS, Yim HJ, Rim CH

Hepatocellular carcinoma (HCC) involving the inferior vena cava (IVC) and/or right atrium (RA) is a rare and intractable disease. A standard treatment has not been established yet, owing to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer

Ock CY, Yoo SH, Keam B, Kim M, Kim TM, Jeon YK, Kim DW, Chung DH, Heo DS

BACKGROUND/AIMS: Although crizotinib is standard chemotherapy for advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), clinical factors affecting progression-free survival (PFS) have not been reported. The purpose of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes

Joo JH, Kim SS, Son BH, Ahn SD, Jung JH, Choi EK, Ahn SH, Lee JW, Kim HJ, Ko BS

PURPOSE: Axillary lymph node dissection (ALND) may be avoidable for breast cancer patients with 1-2 positive lymph nodes (LN) after breast-conserving therapy. However, the effects of ALND after mastectomy remain...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma

Kang HW, Park H, Seo SP, Byun YJ, Piao XM, Kim SM, Kim WT, Yun SJ, Jang W, Shon HS, Ryu KH, Lee SC, Kim WJ, Kim YJ

BACKGROUND: Little is known about epigenetic silencing of genes by promoter hypermethylation in renal cell carcinoma (RCC). The aim of this study was to identify prognostic methylation markers in surgically...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Park SE, Noh JM, Kim YJ, Lee HS, Cho JH, Lim SW, Ahn YC, Pyo H, Choi YL, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ

PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival

Oh J, Lee JM, Park J, Joo I, Yoon JH, Lee DH, Ganeshan B, Han JK

OBJECTIVE: To investigate the usefulness of computed tomography (CT) texture analysis (CTTA) in estimating histologic tumor grade and in predicting disease-free survival (DFS) after surgical resection in patients with hepatocellular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment

Tseng JS, Yang TY, Chen KC, Hsu KH, Huang YH, Su KY, Yu SL, Chang GC

PURPOSE: Epidermal growth factor receptor (EGFR) T790M mutation serves as an important predictor of osimertinib efficacy. However, little is known about how it works among patients with various timings of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients

Guo Q, Wen R, Shao B, Li Y, Jin X, Deng H, Wu J, Su F, Yu F

PURPOSE: The long non-coding RNA H19, a conservatively imprinted gene, acts as a molecular sponge for the let-7 family, which has been identified as a set of tumor suppressors. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate

Lee JH, Kim OL, Seo YB, Choi JH

OBJECTIVE: Atypical meningioma is rare tumor and there is no accurate guide line for optimal treatment. This retrospective study analyzed the prognostic factors, the effect of different methods of treatments...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer

Paik ES, Sohn I, Baek SY, Shim M, Choi HJ, Kim TJ, Choi CH, Lee JW, Kim BG, Lee YY, Bae DS

PURPOSE: This study was conducted to evaluate the prognostic significance of pre-treatment complete blood cell count (CBC), including white blood cell (WBC) differential, in epithelial ovarian cancer (EOC) patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence

Kim MY, Kim JH, Kim Y, Byun SJ

PURPOSE: To investigate the outcomes of postoperative radiotherapy (RT), in patients with extrahepatic bile duct (EHBD) cancer by comparing the survival rate between patients undergoing surgery alone or surgery plus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Value of Metabolic Tumor Volume on 11C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma

Yoo MY, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, Kang KW

PURPOSE: C-11 methionine (MET) PET is commonly used for diagnosing high-grade glioma (HGG). Recently, volumetric analysis has been widely applied to oncologic PET imaging. In this study, we investigated the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib

Park DI, Kim SY, Kim JO, Jung SS, Park HS, Moon JY, Chung CU, Kim SS, Seo JH, Lee JE

BACKGROUND: The efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy can be measured based on the rate of treatment response, based on the Response Evaluation Criteria in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer

Park MR, Park YH, Choi JW, Park DI, Chung CU, Moon JY, Park HS, Jung SS, Kim JO, Kim SY, Lee JE

BACKGROUND: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical course. Although many efforts have been made to improve patients' survival rates, patients who survive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer

Kim J, Lim ST, Na CJ, Han YH, Kim CY, Jeong HJ, Sohn MH

  • KMID: 2139215
  • Nucl Med Mol Imaging.
  • 2014 Mar;48(1):33-40.
PURPOSE: We performed this study to evaluate the predictive value of pretreatment F-18 FDG PET/CT for progression-free survival (PFS) in patients with gastric cancer. METHODS: Of 321 patients with a diagnosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma

Ahn SH, Kim SH, Choi GH, Choi JS, Kim KS

PURPOSE: Although many patients with hepatocellular carcinoma experience recurrence within 2 years after hepatectomy, some patients with T1 and T2 hepatocellular carcinoma show recurrence-free survival for more than 5 years...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Twist Expression in Upper Urinary Tract Urothelial Carcinoma Affects Patients Disease Free Survival and is Associated with Tumor Grade

Kim DI, Yoon SO, Park SY, Kim B, Kang GH, Moon KC

  • KMID: 1521626
  • Korean J Pathol.
  • 2007 Oct;41(5):324-328.
BACKGROUND: Epithelial-mesenchymal transition (EMT) is critical for morphogenesis during embryonic development and is also implicated in the conversion of early-stage tumors into invasive malignancies. Recently, Twist has been identified to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ten Year Disease-free Survival of a Patient after Modified Hepatoligamentopancreatoduodenectomy for Diffuse Hilar Cholangiocarcinoma with Paraaortic Lymph Node Metastases: A Case Report

Jung DH, Lee SG, Kim MH, Sung GB

  • KMID: 2244483
  • Korean J Hepatobiliary Pancreat Surg.
  • 2006 Sep;10(3):42-46.
A 39-year-old female patient presenting with epigastric discomfort and jaundice was diagnosed as diffuse hilar cholangiocarcinoma with vascular tumor invasion. After preoperative management with percutaneous transhepatic biliary drainage and right...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can 3-year Disease-free Survival be Substituted for 5-year Overall Survival in Curatively Resected Gastric Cancer?

Kwon SJ, Kim HJ, Kim MK

  • KMID: 2372779
  • J Korean Gastric Cancer Assoc.
  • 2005 Sep;5(3):174-179.
PURPOSE: The 5-year survival rate is the most useful parameter for evaluating the effect of management on most malignant tumors. Recurrence after a curative resection for gastric cancer occurs mostly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Long-Term Survival and Disease Free Survival after Liver Resection for Hepatocelluar Carcinoma

Yun HR, Lee KW, Heo JS, Choi SH, Kim SJ, Kim YI, Joh JW

  • KMID: 1844419
  • J Korean Surg Soc.
  • 2005 Jun;68(6):479-486.
PURPOSE: Liver resection has been the treatment of choice for a hepatocellular carcinoma (HCC) but the survival rates remain low, and recurrences common. The purpose of this study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr